Quantum-Si Incorporated (NASDAQ: QSI) shares were unchanged Wednesday. The firm, a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced the expansion of a roadshow designed to accelerate market education on its Proteus platform and applications for protein sequencing.
Since the Company’s June roadshow update, the Proteus roadshow has continued to expand with additional planned stops across the United States and Europe. Upcoming events include Leiden on September 11th, Paris on September 14th, and London on September 15th, followed by the University of Colorado Anschutz Medical Campus on September 22nd and New York on September 24th.
During the fourth quarter of 2026, the roadshow is scheduled to visit Barcelona on October 14th and Rome on October 16th, in collaboration with the Company’s local channel partner, and Munich on November 2nd and Berlin on November 4th.
The roadshow is complemented by five additional seminars hosted in collaboration with academic, clinical research, and biopharma partners at select locations across the United States and Europe. Together, these events are designed to broaden engagement with key customer audiences ahead of the commercial launch of Proteus, while supporting continued market education and customer funnel development.
“As we add new stops to the Proteus roadshow, we are seeing strong interest from researchers across academic, clinical research, and biopharma settings who are looking for high-resolution technologies for protein analysis,” said CEO Jeff Hawkins.
QSI shares began Wednesday up 0.067 cents to 76.67 cents.
